Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FQ64K
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,415
Award facts
- Contract value 100% obligated
- $10,414.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,414.65 to DMS Pharmaceutical Group Inc. for the supply of Nexplanon 68 mg implants, with an ultimate completion date of September 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide.
Nexplanon implants are a subdermal contraceptive device that provides long-acting reversible birth control and represents one of many specialized pharmaceutical products within DMS Pharmaceutical Group's extensive federal contract portfolio. As a registered SAM.gov vendor since 2001, the company has consistently demonstrated its capability to supply branded and generic prescription drugs, biologics, medical consumables, and specialty medications to military and federal healthcare systems. This award reflects DMS Pharmaceutical Group's established position as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in DLA procurements.
Quick answers
Who was awarded contract SPE2DB25FQ64K?
SPE2DB25FQ64K was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FQ64K worth?
The government has obligated $10,415 on SPE2DB25FQ64K.
Is contract SPE2DB25FQ64K an order under another contract?
Yes. SPE2DB25FQ64K is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB25FQ64K competed?
The extent of competition for SPE2DB25FQ64K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award